AU2001267165A1 - Prevention and treatment of mycoplasma-associated diseases - Google Patents
Prevention and treatment of mycoplasma-associated diseasesInfo
- Publication number
- AU2001267165A1 AU2001267165A1 AU2001267165A AU6716501A AU2001267165A1 AU 2001267165 A1 AU2001267165 A1 AU 2001267165A1 AU 2001267165 A AU2001267165 A AU 2001267165A AU 6716501 A AU6716501 A AU 6716501A AU 2001267165 A1 AU2001267165 A1 AU 2001267165A1
- Authority
- AU
- Australia
- Prior art keywords
- mycoplasma
- prevention
- treatment
- associated diseases
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000204031 Mycoplasma Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0002989-0A BR0002989A (en) | 2000-07-03 | 2000-07-03 | Anti-mycoplasma medication and its associations with other infectious agents |
| BRPI0002989-0 | 2000-07-03 | ||
| PCT/BR2001/000083 WO2002002050A2 (en) | 2000-07-03 | 2001-07-03 | Prevention and treatment of mycoplasma-associated diseases |
| BRNOTGIVEN | 2001-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001267165A1 true AU2001267165A1 (en) | 2002-01-14 |
Family
ID=3944635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001267165A Abandoned AU2001267165A1 (en) | 2000-07-03 | 2001-07-03 | Prevention and treatment of mycoplasma-associated diseases |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2001267165A1 (en) |
| BR (1) | BR0002989A (en) |
| WO (1) | WO2002002050A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003213898A1 (en) * | 2002-03-28 | 2003-10-13 | Maria De Lourdes Higuchi | Prevention and treatment of mycoplasma-associated diseases |
| US7674832B2 (en) | 2003-03-28 | 2010-03-09 | Higuchi Maria De Lourdes | Compositions for promoting wound healing and treating psoriasis |
| BRPI1004987A2 (en) | 2010-11-26 | 2013-03-26 | Maria De Lourdes Higuchi | prevention and treatment of mycoplasma-associated diseases |
| US8822232B2 (en) | 2003-03-28 | 2014-09-02 | Maria De Lourdes Higuchi | Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation |
| US7732410B2 (en) | 2003-03-28 | 2010-06-08 | Higuchi Maria De Lourdes | Compositions for inhibiting atherosclerosis |
-
2000
- 2000-07-03 BR BR0002989-0A patent/BR0002989A/en not_active Application Discontinuation
-
2001
- 2001-07-03 WO PCT/BR2001/000083 patent/WO2002002050A2/en not_active Ceased
- 2001-07-03 AU AU2001267165A patent/AU2001267165A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002050A3 (en) | 2002-08-15 |
| WO2002002050A2 (en) | 2002-01-10 |
| BR0002989A (en) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003290548A1 (en) | Prevention and treatment of synucleinopathic disease | |
| WO2001078781A8 (en) | Methods for prevention and treatment of gastrointestinal disorders | |
| AU2001269314A1 (en) | Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds | |
| AU2002237667A1 (en) | Methods for the treatment and prevention of urinary stone disease | |
| AUPQ622600A0 (en) | Treatment and/or prevention of ocular pain | |
| AU2002231206A1 (en) | Treatment of depression | |
| AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
| AU2001259085A1 (en) | Treatment of ocular neovascularization and related diseases | |
| AU5908300A (en) | Prevention and treatment of amyloid-associated disorders | |
| AU6887101A (en) | Copolymers and methods of treating prion-related diseases | |
| AU7601400A (en) | Treatment and prevention of hepatic disorders | |
| AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
| AU2002220257A1 (en) | Methods of treatment involving human mda-7 | |
| AU2001245414A1 (en) | Treatment of allergies | |
| AU2001232345A1 (en) | Compositions for preventing and treating digestive diseases | |
| AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2002222125A1 (en) | Prevention and treatment of tachyphylactic response | |
| AU2000275035A1 (en) | Therapeutic and prophylactic drugs of myopia | |
| AU2001258575A1 (en) | Treatment of cancer and neurological diseases | |
| AU2001262741A1 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
| AU1405001A (en) | Treatment of diseases | |
| AU3735900A (en) | Methods of treatment and prevention of restenosis | |
| AU2001255168A1 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU1392601A (en) | Prevention and treatment of biomaterial-associated infections |